Skip to main content

Advertisement

Table 3 Participants’ baseline demographic characteristics and symptom scores

From: A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis

Variable Overall (N = 66) Variable Overall (N = 66)
Age (yrs)   Baseline sneezing score
 Mean 35.0  Mean 2.1
 Std. 9.88  Std. 0.97
 Median 34.5  Median 2.0
 Min. to Max. 21-63  Min. to Max. 0-3
Gender   Baseline runny nose score
 Male 27 (41%)  Mean 2.7
 Female 39 (59%)  Std. 0.44
Ethnicity    Median 3.0
 Hispanic 0 (0%)  Min. to Max. 2-3
 Not Hispanic 66 (100%) Baseline nasal itching score
Race    Mean 2.6
 Caucasian 64 (97%)  Std. 0.55
 Black 0 (0%)  Median 3.0
 Asian 2 (3%)  Min. to Max. 1-3
 American Indian/Alaska Native 0 (0%) Baseline stuffy nose score  
 Native Hawaiian/Other Pacific Islander 0 (0%)  Mean 2.6
 Other 0 (0%)  Std. 0.52
Height (cm)    Median 3.0
 Mean 168.2  Min. to Max. 1-3
 Std. 8.70 Baseline teary eyes score  
 Median 168.0  Mean 2.0
 Min. to Max. 153-188  Std. 0.73
Weight (kg)    Median 2.0
 Mean 79.6  Min. to Max. 1-3
 Std. 16.77 Baseline itchy eyes score  
 Median 79.0  Mean 2.4
 Min. to Max. 50-125  Std. 0.75
BMI (kg/m 2 )    Median 3.0
 Mean 28.11  Min. to Max. 1-3
 Std. 5.478 Baseline total nasal symptom score
 Median 27.04  Mean 7.4
 Min. to Max. 19.1-42.8  Std. 1.21
   Median 7.0
    Min. to Max. 5-9
  1. Baseline is the 90-minute evaluation after the beginning of the allergen challenge for the baseline period prior to dosing period 1.